Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 28, 2025, Astrana Health (ASTH) has a market cap of $1.42 billion USD. According to our data, Astrana Health is ranked No.4583 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 28, 2025 | $1.42 B |
-1.08%
|
| Dec 31, 2024 | $1.44 B |
-17.68%
|
| Dec 29, 2023 | $1.75 B |
29.44%
|
| Dec 30, 2022 | $1.35 B |
-59.73%
|
| Dec 31, 2021 | $3.35 B |
302.19%
|
| Dec 31, 2020 | $0.83 B |
-0.76%
|
| Dec 31, 2019 | $0.84 B |
-7.25%
|
| Dec 31, 2018 | $0.91 B |
-17.29%
|
| Dec 29, 2017 | $1.10 B |
220.00%
|
| Dec 30, 2016 | $0.34 B |
57.89%
|
| Dec 31, 2015 | $0.22 B |
5.56%
|
| Dec 31, 2014 | $0.21 B |
-30.77%
|
| Dec 31, 2013 | $0.30 B |
30.00%
|
| Dec 31, 2012 | $0.23 B |
233.33%
|
| Dec 30, 2011 | $68.48 M |
0.00%
|
| Dec 31, 2010 | $68.48 M |
114.29%
|
| Dec 31, 2009 | $31.96 M |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Teladoc Health
TDOC
|
$1.27 B |
10.512 M
|
USA
|
 American Well
AMWL
|
$0.12 B |
14.614 M
|
USA
|
 Health Catalyst
HCAT
|
$0.29 B |
0.000 M
|
USA
|
 Allscripts
MDRX
|
$0.48 B |
0.000 M
|
USA
|
 Evolent Health
EVH
|
$1.06 B |
12.823 M
|
USA
|
 Phreesia
PHR
|
$1.45 B |
0.000 M
|
USA
|
 Omnicell
OMCL
|
$1.46 B |
11.712 M
|
USA
|
| Market Cap | = | ASTH Stock Price | * | ASTH Shares Outstanding |
| = | $30.60 | * | 45.35 M | |
| = | $1.42 B |